参考文献/References:
[1] Han S,Sung PS,Park SY,et al.Local ablation for hepatocellular carcinoma:2024 expert consensus-based practical recommendations of the Korean Liver Cancer Association[J].Gut Liver,2024,18:789-802.
[2]陈晓明,张 靖,祖茂衡.加强肝癌根治性介入治疗的理念与临床研究[J].介入放射学杂志,2025,34:805-807.
Chen XM,Zhang J,Zu MH.Strengthening the concept and clinical research of radical interventional therapy for hepatocellular carcinoma[J].J Interv Radiol,2025,34:805-807.
[3]刘 璐,吴发宗,应希慧,等.最新肝癌诊疗指南中有关局部消融治疗的更新进展[J].肝胆胰外科杂志,2025,37:163-166.
Liu L,Wu FZ,Ying XH,et al.Updates on local ablation therapy in the latest guidelines for diagnosis and treatment of hepatocellular carcinoma[J].J Hepatopancreatobiliary Surg,2025,37:163-166.
[4]Nakla T,Chow JJ,Pham K,et al.Non-thermal liver ablation:existing and new technology[J].Semin Intervent Radiol,2024,40:497-504.
[5]Wang Z,Liu M,Zhang DZ,et al.Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5 cm HCC[J].Hepatology,2022,76:66-77.
[6]Vietti Violi N,Duran R,Guiu B,et al.Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease:a randomised controlled phase 2 trial[J].Lancet Gastroenterol Hepatol,2018,3:317-325.
[7]余 萱,贺需旗,郭光辉,等.新型微波消融系统治疗血管旁与非血管旁肝癌的安全性及疗效[J].中华肝脏外科手术学电子杂志,2025,14:888-893.
Yu X,He XQ,Guo GH,et al.Safety and efficacy of a novel microwave ablation system in the treatment of hepatocellular carcinoma adjacent to and away from blood vessels[J].Chin J Hepat Surg(Electron Ed),2025,14:888-893.
[8]Reig M,Sanduzzi-Zamparelli M,Forner A,et al.BCLC strategy for prognosis prediction and treatment recomme-ndations:The 2026 update[J].J Hepatol,2025,84:631-654.
[9]中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版)[J].中华消化外科杂志,2024,23(4):429-478.
National Health Commission of the People's Republic of China,Department of Medical Administration.Standard for diagnosis and treatment of primary liver cancer(2024 edition)[J].Chin J Dig Surg,2024,23(4):429-478.
[10]Min JH,Lee MW,Rhim H,et al.Prognosis after curative resection of single hepatocellular carcinoma with a focus on LI-RADS targetoid appearance on preoperative gadoxetic acid-enhanced MRI[J].Korean J Radiol,2021,22:1786-1796.
[11]Liu H,Zhang J,Zeng H,et al.Assessment of intrahepatic cholangiocarcinoma with LI-RADS in the high-risk population:MRI diagnosis and postoperative survival[J].Cancer Imaging,2025,25:40.
[12]Hong SB,Choi SH,Kim SY,et al.MRI features for predicting microvascular invasion of hepatocellular carcinoma:a systematic review and meta-analysis[J].Liver Cancer,2021,10:94-106.
[13]Imai K,Yamashita YI,Yusa T,et al.Microvascular invasion in small-sized hepatocellular carcinoma:significance for outcomes following hepatectomy and radiofrequency ablation[J].Anticancer Res,2018,38:1053-1060.
[14]Yoo J,Lee MW,Lee DH,et al.Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma[J].Liver Int,2020,40:1189-1200.
[15]Fang Y,Hu FX,Ren WW,et al.Nanomedicine-unlocked radiofrequency dynamic therapy dampens incomplete radiofrequency ablation-arised immunosuppression to suppress cancer relapse[J].Biomaterials,2025,317:123087.
[16]Guo YS,Ren YQ,Dong XJ,et al.An overview of hepatocellular carcinoma after insufficient radiofrequency ablation[J].J Hepatocell Carcinoma,2022,9:343-355.
[17]Huang N,Fang YS,Zheng ST,et al.Residual tumor cells after insufficient radiofrequency ablation promote lung metastasis by educating CD177(hi)PAD4(hi)neutrophils[J].Nat Commun,2025,16:1234.
[18]Guo P,Zheng J,Pi X,et al.Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma:insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis[J].Front Oncol,2024,14:1283843.
[19]Xu Y,Wang Z,Liang Y,et al.Accurate multimodal liver registration of 3D ultrasound and CT volume:an open dataset and a model fusion method[J].Biomed Signal Process Control,2025,98:106656.
[20]de Baere T,Roux C,Deschamps F,et al.Evaluation of a new CT-guided robotic system for percutaneous needle insertion for thermal ablation of liver tumors:a prospective pilot study[J].Cardiovasc Intervent Radiol,2023,46:1433-1441.
[21]Harari CM,Magagna M,Bedoya M,et al.Microwave ablation:comparison of simultaneous and sequential activation of multiple antennas in liver model systems[J].Radiology,2016,278:95-103.
[22]Minier C,Hermida M,Allimant C,et al.Software-based assessment of tumor margins after percutaneous thermal ablation of liver tumors:a systematic review[J].Diagn Interv Imaging,2022,103:240-250.
(收稿日期:2025-12-09)
(本文编辑:谷 珂)
相似文献/References:
[1]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].J Intervent Med,2010,(04):328.
[2]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].J Intervent Med,2010,(04):382.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].J Intervent Med,2010,(04):540.
[4]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].J Intervent Med,2010,(04):535.
[5]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].J Intervent Med,2005,(04):442.
[6]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[7]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[8]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].J Intervent Med,2009,(04):185.
[9]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].J Intervent Med,2009,(04):437.
[10]王惠文,刘瑞宝,刘 岩,等.原发性肝癌ＴＡＣＥ后ＦＡＫ、ＮＦκＢｐ６５表达及意义[J].介入放射学杂志,2011,(08):621.
WANG Hui-wen,LIU Rui-bao,LIU Yan,et al.The expression and significance of FAK and NF-κBp65 in hepatocellular carcinoma after transcatheter arterial chemoembolization[J].J Intervent Med,2011,(04):621.